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WHAT THIS PAPER ADDS
 This is the ﬁrst systematic review of Cardiopulmonary Exercise Testing in vascular surgery. It identiﬁes an absence of evidence for
CPET in clinical practice prior to AAA repair or lower extremity arterial bypass. CPET should not be used to guide routine practice in
the absence of evidence; formal research of its role is required.a r t i c l e i n f o
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Objective: To perform a systematic review of cardiopulmonary exercise testing (CPET) in the pre-
operative evaluation of patients with abdominal aortic aneurysm or peripheral vascular disease
requiring surgery.
Methods: Review methods and reporting were according to the PRISMA guidelines. Studies were eligible
if they reported CPET-derived physiological parameters in patients undergoing abdominal aortic aneu-
rysm repair or lower extremity arterial bypass. Data were extracted regarding patient populations and
correlation between CPET and surgical outcomes including mortality, morbidity, critical care bed usage
and length of hospital stay.
Results: The searches identiﬁed 1301 articles. Although 53 abstracts referred to the index vascular
procedures, only seven articles met inclusion criteria. There were no data from randomised controlled
trials. Data from prospective studies did not comprehensively correlate CPET and surgical outcomes in
patients with abdominal aortic aneurysms. There were no studies reporting CPET in patients undergoing
lower extremity arterial bypass. Major limitations included small sample sizes, lack of blinding, and an
absence of reporting standards.
Conclusion: The paucity of robust data precludes routine adoption of CPET in risk stratifying patients
undergoing major vascular surgery. The use of CPET should be restricted to clinical trials and experi-
mental registries, reporting to consensus-deﬁned standards.
Crown Copyright  2012 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. All
rights reserved.Introduction
Abdominal aortic aneurysm (AAA) and peripheral vascular
disease are pathologies of the ageing population and oftentions on this paper, please go
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esalingam).
012 Published by Elsevier Ltd onpresent in patients with a number of medical co-morbidities.1,2
Co-existing cardio-respiratory and renal disease have a signiﬁ-
cant effect on the outcome of AAA repair3 and lower extremity
arterial bypass (LEAB),4 which are considered “high-risk”
vascular surgery procedures with more than 5% risk of cardiac
events within 30 days.5,6 Careful pre-operative assessment,
risk stratiﬁcation and optimisation for this population is
important, ideally initiated in conjunction with vascular
anaesthetists with referral pathways to other hospital
specialists.7behalf of European Society for Vascular Surgery. All rights reserved.
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practice emphasise the need for assessment of a patient’s ﬁtness or
functional capacity5,8 and state that patients who can demonstrate
more than four metabolic equivalents (climbing two ﬂights of
stairs or running a short distance) can be considered safer to
proceed to surgery without cardiac assessment; but it has been
widely acknowledged that determining functional status in
patients undergoing LEAB or AAA repair can be inaccurate or easily
confounded6 and subjective evaluation by clinicians lacks prog-
nostic accuracy.9 Cardiopulmonary exercise testing (CPET) provides
an objective measure of functional reserve, which can be per-
formed safely in high-risk populations.10,11 CPET is a ramped
exercise test during which the ECG, blood pressure and oxygen
saturations are monitored, and respiratory variables, including
oxygen uptake and carbon dioxide excretion, are quantiﬁed (Fig. 1).
A number of parameters can be derived including the peak oxygen
uptake (VO2-peak), which is effort-dependent, and oxygen uptake
at the anaerobic threshold (AT), which is unrelated to effort or
motivation.
In the last decade CPET has moved from the realms of the
research laboratory and sports medicine, towards routine clinical
practice. A review of its physiological basis is available with guid-
ance on the interpretation of CPET results in the peri-operative
setting.12 CPET is now of particular interest when a procedure has
a high operative risk, especially where that risk is primarily cardio-
respiratory, in major abdominal or non-cardiac vascular surgery.
AAA repair and LEAB are common procedures with high rates of
adverse peri-procedural events. These patients have especially high
cardiovascular morbidity and mortality, which may be under-
estimated by risk scores such as the revised cardiac risk index
(RCRI).13 Therefore, CPET might be of particular value and its
prognostic value deserves focussed appraisal. AAA repair and LEAB
might also be considered models around which to base CPET
services and to better understand the extent to which CPET is
predictive of surgical outcome.
This review collates the available data regarding the use of CPET
in the pre-operative assessment and risk stratiﬁcation of patients
undergoing AAA repair or LEAB. Where possible the review aims to
correlate CPET data, and AT and VO2-peak in particular, with peri-
operative morbidity and mortality, length of hospital stay and the
need for critical care.
Methods
This systematic review conformed to the PRISMA statement
standards.14,15 The population of interest was all patients under-
going AAA repair or LEAB surgery. The intervention studied wasFigure 1. Photograph of CPET procedure (cardiopulmonary exercise test).the use of CPET in pre-operative risk stratiﬁcation and in selection
of patients for these index procedures. In particular the relation-
ship of AT and VO2-peak to surgical outcomes was investigated.
Primary outcome measures were peri-operative and mid-term
morbidity and mortality, the length of hospital stay and the need
for critical care after surgery. Inclusion criteria speciﬁed studies
that reported these outcome data alongside CPET results for the
index procedures.
A literature search was undertaken of Pubmed, EMBASE, the
Cochrane libraries and Google Scholar. Grey literature (material not
formally produced by publishers or peer-reviewed journals) and
conference proceedings were included by searching GreyNet, the
Conference Proceedings Citation Index on the Web of Science and
Zetoc giving access to the British Library’s Electronic Table of
Contents. Searches included all articles up to 1st November 2011.
The search terms CPET, CPEX, CPX, CPET and cardiopulmonary
exercise test were employed. The results were limited to human
studies published in English and then conﬁned to those involving
patients over the age of 45 years, which includes the large majority
of patients with atherosclerotic abdominal aortic aneurysms and
peripheral vascular disease. The results were further limited by the
inclusion of the terms: vascular surgery, abdominal aortic aneu-
rysm, peripheral vascular disease, lower limb arterial bypass and
lower extremity arterial bypass. Duplicate articles were excluded
and the remaining abstracts reviewed for suitability. The remaining
articles were withdrawn for detailed evaluation and inclusion in
the review process.
The minimum information required from each article was
established prior to data abstraction by the authors. EY & PH
reviewed the abstracts and agreed the ﬁnal articles to be included
in the review. Datawere extracted in duplicate by the same authors
using agreed proformas. Differences were resolved by consensus.
The data extracted included study design, sample size, the
speciﬁc procedure undertaken, the AT and VO2-peak used to deﬁne
patients as being ‘high-risk’ and the mortality rate for high- and
low-risk groups. Relevant correlations of key CPET variables and
outcomes other than mortality have been listed above. Any other
CPET variables were extracted as secondary measures, as were
comparisons of CPET and other risk stratiﬁcation systems such as
stress echocardiography or APACHE scores. The major conclusion
from each article was recorded.
Heterogeneity in methodology and outcome measures
precluded meta-analysis and prevented a quantitative assessment
of publication bias. The nature of this review did not allow for the
assessment of patient-level data and so the degree of within-study
selection or reporting bias was not possible to quantify. Similarly,
summary measures, synthesis methods and sensitivity analyses
were not employed due to the subject of this review.
In summary, the principal data extracted were CPET results,
notably AT and VO2-peak in AAA repair and LEAB surgery, and the
published relationship between these CPET results with early and
mid-term surgical outcomes.
Results
After limits were applied, the searches identiﬁed 1301 articles or
abstracts regarding the use of CPET. Of these, 53 abstracts appeared
to refer to the vascular surgical procedures of interest. In total, 6
published articles were included in the ﬁnal review, with infor-
mation relating speciﬁcally to CPET in AAA patients.9,10,16e19 No
articles reported CPET in the assessment of patients with peripheral
vascular disease prior to LEAB. A further 7 relevant abstracts were
identiﬁed from conference proceedings.11,20e25 A number of related
articles were included to provide context in the discussion of these
results, but did not meet the inclusion criteria for review in
Figure 2. PRISMA ﬂowchart.
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ﬂowchart).
The data were not presented in a consistent format and there-
fore could not be synthesised through meta-analysis. Consequently
a systematic review was undertaken. The key ﬁndings from
published articles or conference proceedings are summarised in
Tables 1 and 2.
The data available were limited by an absence of high-quality
prospective studies that speciﬁcally reported CPET in AAA repair.
There was no evidence for CPET from completed randomised
controlled trials or studies investigating diagnostic accuracy
(sensitivity and speciﬁcity) for AAA repair or LEAB. The majority of
the literature comprised single centre retrospective case series with
low sample size, with a high-risk of confounding, bias and limited
information on causality.
CPET and abdominal aortic aneurysm repair
A number of prospective studies failed to effectively discrimi-
nate between AAA repair and other high-risk surgical procedures.
Consequently the results did not effectively determine of the role of
CPET in the pre-operative risk assessment of AAA repair.27e29 This
was disappointing as the studies had the opportunity to report both
the correlation between CPET and a mortality outcome and the
triage and use of intensive care facilities. Furthermore, the onlystudy to attempt to compare traditional physiological methods of
risk stratiﬁcation and CPET could not identify a beneﬁt in terms of
predicting complications between the methods.19
Struthers et al. compared three different methods of risk
assessment.10 These were an exercise questionnaire, shuttle walk
and CPET. However, the study was weakened by insufﬁcient power
to detect a difference between patients of different surgical risk, or
to correlate the ﬁndings with surgical outcomes. The authors
concluded that CPET might have some advantages over the other
methods of risk assessment, but these were not quantiﬁed.
A similar study looking at mid-term outcomes of AAA repair
determined that the revised cardiac risk index (RCRI) had an
equivalent predictive value to CPET16 in the setting of AAA repair.
CPET did, however, identify patients who were unlikely to survive
for two years after surgery.
A single centre audit of 88 patients undergoing AAA repair
demonstrated that a “high-risk group” with 19% mortality were
identiﬁed with pre-operative CPET. Its authors speculated that this
group might beneﬁt from endovascular aneurysm repair (EVAR)
rather than open repair,17 although this assertion was not sup-
ported by evidence. A single-centre series of 102 patients with AAA
reported the use of CPET as part of the pre-operative process to
determine ﬁtness for open aneurysm repair.9 In this study, patients
undergoing AAA repair had greater 30-month survival than those
managed conservatively, with a difference in pre-operative CPET
Table 1
Data from published peer-reviewed articles.
Author Study type Subjects Patients Deﬁnition of high-risk Outcomes
assessed
Results Conclusion
Nugent et al.19 Prospective Elective AAA 36 assessed
but only 30
had surgery.
26 were
infrarenal
AAA and 4
juxtarenal
PVO2 < 20 ml/kg/min
Exercise score based on
CPET parameters 2
Complications
Mortality
Length of Stay
12-month
outcome
10% mortality rate (1 peri-operative
and 2 within one year)
30% major complication rate
post-operatively
<10% B-blocked
No differences were found in CPET
results (PVO2 or exercise score) or
traditional risk measures (LVEF, FEV1,
FVC) between patients with or
without complications.
Patients with complications had
a longer length of stay, but this was
not predicted by CPET.
CPET was comparable to standard
work-up for AAA repair.
Kothmann et al.18 Pilot study Small AAA
only
(mean 4 cm)
16 AT assessed, but for
variability not risk
Inter-test
variability in AT.
No surgical
outcomes.
10% variability in AT across four
repeat tests in a six-week period
giving a good intra-class correlation.
Not surgical patients so not correlated
to outcome.
AT is reproducible for patients
with small AAA
Carlisle & Swart16 Retrospective Elective AAA 130 AT <11
Ve/VCO2 >42
Revised Cardiac Risk
Index (RCRI) >1
Mid-term survival
after elective AAA
repair
Correlation of
RCRI, CPET and
physiological risk
scoring systems
(SAPS, APACHE,
POSSUM)
10.7% in-hospital mortality.
22% mid-term mortality (2-years)
CPET correlated with mid-term
survival.
RCRI and CPET had equivalent
predictive value, but when combined
a greater number of patients were
categorised as ﬁt and this correlated
with the subsequent outcome.
RCRI was more predictive of mid-term
survival than CPET.
AT >11 and Ve/VCO2 <43 were
the best predictors of mid-term
survival from CPET.
CPET identiﬁed patients unlikely to
survive in mid-term.
McEnroe & Wilson17 Retrospective Elective AAA 119 AT <11
POSSUM score
Ability to risk
stratify from AT
and history of
ischaemic heart
disease.
No statistical
analysis reported.
No differences were seen in POSSUM
scores between groups.
CPET identiﬁed high- and low-risk
groups although the majority of
patients in the surgical and “no
surgery” groups had AT <11.
High-risk patients had 19% mortality
cf. 4% low-risk patients.
Not all high-risk patients had surgery.
11% of all patients had a cardiology
referral based on CPET results
CPET may identify patients who should be
undergo EVAR or not be operated on.
Struthers et al.10 Prospective Major
abdominal
surgery
(50 patients)
29 AAA PVO2
AT
CPET correlated to
shuttle walk test
and an exercise
questionnaire.
Not powered to compare clinical
outcomes between ‘ﬁt’ and ‘unﬁt’
groups.
Signiﬁcant correlation between tests
but some patients with poor
questionnaire or shuttle results
passed CPET
CPET may be more reliable than exercise
questionnaires or shuttle tests, but the
relationship to surgical outcome was not
quantiﬁed.
Thompson et al.9 Retrospective 102 patients
with AAA
66 deemed
ﬁt for AAA
repair
AT
VO2 peak
VE/VCO2
VE/VO2
Death
Major Morbidity
AT correlated with 30-month survival
and major complications. No
correlation of VCO2 or VO2 to survival
AT may be a useful predictor of all-cause
survival in all patients referred with AAA.
But CPET results inﬂuenced the decision to
operate for AAA, and aneurysm-related
death remained unknown in both
conservative and operated patients. A
confounding inﬂuence might have arisen
from aneurysm rupture in patients turned
down for repair because of poor CPET
performance
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Table 2
Data from conference proceedings available in the grey literature.
Author Study type Subjects Patients Deﬁnition
of high-risk
Outcomes assessed Results Conclusion
Khan et al.21 Prospective,
RCT
Elective
AAA repair
30 Not stated Correlation between
AT, LVEF and stair
climb
Strong correlation between
stair climb and CPET deﬁned AT
Stair climb might be as
useful as CPET
Khan et al.20 Prospective,
RCT
Elective
AAA repair
30 Not stated Mortality Patients who died in AAA repair
had a lower AT than those who
survived (6.67 vs. 12.8;
p ¼ 0.042). EVAR/OAR not
stated
CPET might be a useful
tool in risk
stratiﬁcation for AAA
repair
Khan et al.22
(repeat publication)
Prospective,
RCT
Elective
AAA repair
30 Not stated Mortality Patients who died in AAA
repair had a lower AT than
those who survived (6.67 vs.
12.8; p ¼ 0.042). EVAR/OAR
not stated
CPET might be a useful
tool in risk
stratiﬁcation for AAA
repair
Yow et al.25 Retrospective Elective
AAA repair
99 AT <11 Mortality
Length of stay
Cost
If AT <11 then conservative
management or EVAR
depending on morphology.
Mortality rate 14.3% pre-CPET
vs. 3.7% post-CPET introduction
but large increase in EVAR use
in same timeframe (19%e46%).
Reduced LOS and ITU use.
Reduced cost.
CPET use can reduce
mortality cost and
length of stay after AAA
repair. Patients can be
risk stratiﬁed to
conservative
management or EVAR
based on AT.
West et al.24 Retrospective Elective
AAA repair
49 Not stated Fitness for
Surgery
AT was different between the
‘ﬁt’ and ‘unﬁt’ group (10.9 vs
7.3; NS)
Pre-operative CPET
might be a useful tool
prior to AAA repair.
Henry et al.11 Retrospective Elective
AAA repair
12 Not stated Feasibility Descriptive data only, not
correlated with outcome
CPET is feasible in
a district general
hospital
Lancaster et al.23 Retrospective Elective
EVARs
100 Not stated Mortality VE/VCO2 was associated with an
improvement in survival with
EVAR. ROC analysis suggested
a cut off of VE/VCO2 44, but
this was non-signiﬁcant
CPET might be useful in
identifying patients at
a higher risk of
mortality after EVAR
Kordowicz et al.26 Retrospective Elective
AAA repair
134
(70 open &
64 EVAR)
Not Stated 1-year mortality Peak VO2 was lower in
non-survivors (15.3 vs. 12.4;
p ¼ 0.03)
AT not different between
groups (10.7 vs. 10.6)
CPET might help
predict those patients
that will not beneﬁt
from surgery.
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surgical or conservative management. A lower anaerobic threshold
was associated with 30-month survival in the combined cohort of
operated and unoperated patients, with an area of 0.694 under the
ReceivereOperator Characteristic curve. In those who underwent
open AAA repair, anaerobic threshold was associated with major
post-operative complications.
The results from the grey literature are presented in Table 2. A
number of single centre case series suggested that the use of CPET
in the assessment of patients undergoing aneurysm repair was
possible and that it could be performed safely.11,20e26 Two
abstracts presented similar information.20,22 As anticipated, the
abstracts presented only basic details, but suggested that there
might be role for CPET in terms of stratifying patients to open
aneurysm repair or EVAR and that this, in conjunction with the
lower peri-operative mortality seen with EVAR, might reduce the
mortality after aneurysm repair. Reductions in hospital length of
stay and ITU use were also suggested in ‘ﬁt’ patients as opposed to
those deemed ‘unﬁt’ by CPET, with no explicit deﬁnition of ‘ﬁtness’
by CPET variables.
CPET and peripheral vascular disease
There was no evidence in the literature on the use of CPET in
patients undergoing lower extremity arterial bypass, or correlating
CPET results to surgical outcomes in the setting of peripheral
vascular disease.Discussion
This systematic review highlighted the incomplete evidence
base for CPET in risk assessment before vascular surgery. The major
limitations are small sample sizes, a lack of blinding and an absence
of reporting standards. Despite the theoretical promise of CPET for
assessing functional capacity and predicting cardiopulmonary
morbidity in these high-risk patients, more robust data are
required to justify its routine implementation in clinical practice.
The paucity of available evidence is surprising considering the
availability of CPET facilities in the UK; 53/166 (32%) of all anaes-
thetic departments in England have access to CPET services and of
these, 38/53 (72%) use CPET in the pre-operative assessment of
vascular surgical patients.30
The evidence for CPET should be appraised in light of other
methods for measuring functional risk, and in the context that
current guidelines for peri-operative evaluation before AAA
repair and LEAB do not include CPET.5 Alternative measures
include scoring systems such as the revised cardiac risk index
(RCRI) or the Glasgow aneurysm score (GAS) and inpatient
investigations such as echocardiography, pulmonary function
tests and dobutamine stress echocardiography. Whilst a meta-
analysis of these methods has been performed, a suitable
comparison to CPET has not been established.31 An appropriately
powered comparison between CPET and these other measures
would quantify the role of CPET in terms of surgical outcome,
critical care bed usage and hospital length of stay as well as
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only one small, randomised trial attempted to compare echo-
cardiography, stair climbing and CPET. The results suggested that
stair climbing might be as useful as CPET in risk stratiﬁcation of
patients.21 Risk-adjusted population data have failed to demon-
strate that echocardiography improves outcomes in major elec-
tive non-cardiac surgery and a similar analysis for CPET would be
a valuable addition to the literature.32
Reporting standards
The most common recommendation in the studies reviewed
was that an AT of <11 ml O2/kg/min and VO2-peak of <20 ml O2/
kg/min deﬁned a high-risk surgical patient, but these variables
were neither universally reported nor correlated to outcome.
Other variables such as Ve/VCO2 and Ve/VO2 were rarely reported
and, despite their possible signiﬁcance,23 are unlikely to be
meaningful without correlation to high-quality outcomes data.
The consensus statement deﬁning accurate reporting standards
for CPET-based studies is a vital addition to the literature.33 An
arbitrary threshold of AT <11 ml O2/kg/min was popularised after
prognostic studies in patients with chronic heart failure,34 but this
value has not been validated in patients undergoing major
surgery.29,35
Limitations of the existing data
All patients with vascular disease should undergo a thorough
assessment of their cardiac risk. At present, referral for more
sophisticated testing such as CPET remains subjective, which
reduces the strength of existing evidence. Plasma biomarkersmight
identify those at greatest risk of cardiopulmonary morbidity,36,37
and it may be that CPET is most appropriately limited to this
selected “high-risk” subset of patients who require a quantitative
assessment of functional capacity rather being proposed for every
patient.
Technical limitations affect those with peripheral vascular
disease in particular; patients with short distance claudication or
rest painmay have difﬁculty in using a treadmill or cycle ergometer,
although some with moderate calf claudication alone are able to
complete the cycle test. This is in part due to symptoms, but also
differences in muscle mass and training.38 Arm-bikes have been
proposed for this setting, but the algorithms for interpreting the
results remain uncertain as the VO2-peak only reaches 70% of that
from leg exercise and lactate levels rise earlier.39e41 These difﬁ-
culties are addressed in some units by using failure to complete
a CPET assessment as a marker of severe cardiac disease and
a completed CPET test as indication of sufﬁcient reserve to undergo
surgery. Certainly, the inability to complete a CPET test identiﬁes
a particularly high-risk group and mandates referral for non-
invasive cardiac testing.42,43
Existing data correlating CPET with mid-term survival in
patients with AAA is compromised by the lack of blinding to CPET
assessment and the role of CPET in allocating treatment decisions.9
The correlation of CPET with survival in non-blinded studies is
confounded by the possibility of aneurysm rupture in patients
deemed unﬁt for AAA repair due to poor CPET performance, rather
than poor CPET performance reﬂecting a greater propensity for
non-AAA related death in this group. This study was limited by the
data available, the paucity and heterogeneity of which precluded
meta-analysis, assessment of patient-level data or quantiﬁcation of
selection or reporting bias.
Nonetheless the present systematic review demonstrates
a paucity of evidence for CPET prior to AAA repair or LEAB; the
routine use of CPET prior to offering patients these operationscannot be recommended. Further investigation of CPET prior to
high-risk vascular surgery should occur in a research setting.
Recommendations for future research
Blinded studies of pre-operative CPET in vascular patients are
required to remove selection bias from analysis of its association
with post-operative morbidity. CPET parameters such as VO2-peak
can be improved by supervised exercise before surgery.44 Further
studies should therefore incorporate optimisation periods prior to
ﬁnal assessment where this is clinically feasible and surgical
intervention is not emergent.
Future studies must also take into account that more AAAs are
now routinely excluded by EVAR than by open repair.1 EVAR is
a minimally invasive technique delivered at a mortality of less than
1% with low morbidity in the best centres.45 The critical care bed
usage is low, with the majority of EVARs nursed in a standard ward
setting with short hospital stay. It is therefore possible that
CPET might be less valuable in EVAR than in open repair. Further-
more, traditional risk stratiﬁcation variables appear to play a lesser
role in the outcome of AAA repair by EVAR than aneurysm
morphology,3,46,47 and in the endovascular era traditional physio-
logical scoring systems lack validity for the subset of patients
undergoing open repair.48 Although the less invasive nature of
EVAR is associated with lower 30-day mortality than open repair,
surprisingly, randomised data have demonstrated no difference in
the rate of adverse post-operative cardiac events.49 It would
therefore still be useful to evaluate whether CPET plays a role in
identifying which patients undergoing EVAR need critical care,
which patients might undergo day-case procedures and which
patients should not be offered treatment on the basis of poor long-
term prognosis.16,26
Conclusion
An objective review of the literature demonstrates that the
evidence for pre-operative testing using CPET is insufﬁcient.
Unblinded, single-centre series have shown a correlation between
CPET and all-cause survival in AAA patients, but these data are not
sufﬁciently robust to support the routine use of CPET in pre-
operative selection of patients for AAA repair, particularly in the
endovascular era. In light of the ﬁndings of this systematic review,
themain recommendations are that CPET should not decide patient
selection prior to AAA repair or LEAB in routine practice and its use
should be restricted to formal research; future studies of CPET in
vascular patients should be blinded, adhere to reporting standards,
address patients undergoing EVAR, and should formally correlate
the results of CPET to deﬁned clinical outcomes.
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